Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has provided an update.
Wai Chun Bio-Technology Ltd. has announced a board meeting scheduled for September 30, 2025, to discuss and approve the audited final results for the fiscal year ending June 30, 2025. The meeting will also consider the potential declaration of a final dividend, which could impact the company’s financial positioning and shareholder returns.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, operating within the biotechnology industry. The company focuses on developing and providing biotechnological products and services, although specific market focus details are not provided in the announcement.
Average Trading Volume: 367,334
Technical Sentiment Signal: Buy
Current Market Cap: HK$30.16M
See more insights into 0660 stock on TipRanks’ Stock Analysis page.